Progressive cholangiopathy in COVID-19 patients: Other possible diagnoses than ketamine-induced cholangiopathy should be considered

被引:8
|
作者
Deltenre, Pierre [1 ,2 ]
Moreno, Christophe [1 ,3 ]
Trepo, Eric [1 ,3 ]
机构
[1] Univ Libre Bruxelles, CUB Hop Erasme, Dept Gastroenterol Hepatopancreatol & Digest Onco, Brussels, Belgium
[2] Clin St Luc, Dept Gastroenterol & Hepatol, Bouge, Belgium
[3] Univ Libre Bruxelles, Lab Expt Gastroenterol, Brussels, Belgium
关键词
SCLEROSING CHOLANGITIS;
D O I
10.1016/j.jhep.2021.02.036
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:989 / 990
页数:2
相关论文
共 50 条
  • [41] Paracetamol in the home treatment of early COVID-19 symptoms: A possible foe rather than a friend for elderly patients? (vol 93, pg 5704, 2021)
    Pandolfi, S.
    Simonetti, V
    Ricevuti, G.
    Chirumbolo, S.
    JOURNAL OF MEDICAL VIROLOGY, 2022, 94 (03) : 1246 - 1246
  • [42] SARS-CoV-2 RNA more readily detected in induced sputum than in throat swabs of convalescent COVID-19 patients
    Han, Huanqin
    Luo, Qingfeng
    Mo, Fan
    Long, Lieming
    Zheng, Weiqiang
    LANCET INFECTIOUS DISEASES, 2020, 20 (06): : 655 - 656
  • [43] Decreased CO2 Levels as Indicators of Possible Mechanical Ventilation-Induced Hyperventilation in COVID-19 Patients: A Retrospective Analysis
    Hu, Di
    Li, Jinpeng
    Gao, Rongfen
    Wang, Shipei
    Li, Qianqian
    Chen, Sichao
    Huang, Jianglong
    Huang, Yihui
    Li, Man
    Long, Wei
    Liu, Zeming
    Guo, Liang
    Wu, Xiaohui
    FRONTIERS IN PUBLIC HEALTH, 2021, 8
  • [44] COVID-19 Induces Greater NLRP3 Inflammasome Activation in Obese Patients than Other Chronic Illnesses: A Case-Control Study
    D'Amico, Raissa Campos
    Nagashima, Seigo
    Carstens, Lucas Baena
    Bertoldi, Karina de Guadalupe
    Mataruco, Sabrina
    Honorio D'Agostini, Julio Cesar
    Hlatchuk, Elisa Carolina
    da Silva, Sofia Brunoro
    de Noronha, Lucia
    Baena, Cristina Pellegrino
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2025, 26 (04)
  • [45] Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
    Trifiro, Gianluca
    Crisafulli, Salvatore
    Ando, Giuseppe
    Racagni, Giorgio
    Drago, Filippo
    DRUG SAFETY, 2020, 43 (06) : 507 - 509
  • [46] Should Patients Receiving ACE Inhibitors or Angiotensin Receptor Blockers be Switched to Other Antihypertensive Drugs to Prevent or Improve Prognosis of Novel Coronavirus Disease 2019 (COVID-19)?
    Gianluca Trifirò
    Salvatore Crisafulli
    Giuseppe Andò
    Giorgio Racagni
    Filippo Drago
    Drug Safety, 2020, 43 : 507 - 509
  • [47] Serum Levels of Chemokine Ligand-7 and Interferon- γ-induced Protein-10: Possible Severity and Prognostic Markers in Patients with COVID-19
    Hassan, Rania Ahmed
    Khattab, Mona A.
    Ezzelregal, Hieba Gamal
    Tawfik, Heba Mohamed
    Gadallah, Shimaa Hussien
    Abdelhamid, Dalia Hosni
    Ahmed, Yasmin Mohamed
    JOURNAL OF PURE AND APPLIED MICROBIOLOGY, 2022, 16 (02): : 1298 - 1306
  • [48] Interleukin-1 blocking agents as promising strategy for prevention of anticancer drug-induced cardiotoxicities: possible implications in cancer patients with COVID-19
    Quagliariello, V.
    Paccone, A.
    Iovine, M.
    Cavalcanti, E.
    Berretta, M.
    Maurea, C.
    Canale, M. L.
    Maurea, N.
    EUROPEAN REVIEW FOR MEDICAL AND PHARMACOLOGICAL SCIENCES, 2021, 25 (21) : 6797 - 6812
  • [49] COVID-19-induced vascular angiopathy: CTPA signs in critically ill patients other than acute pulmonary embolism and high-lung opacity scores
    Khalifa, Mohamed Hossameldin
    Samir, Ahmed
    Baess, Ayman Ibrahim
    Hendawi, Sara Samy
    EGYPTIAN JOURNAL OF RADIOLOGY AND NUCLEAR MEDICINE, 2021, 52 (01):
  • [50] COVID-19-induced vascular angiopathy: CTPA signs in critically ill patients other than acute pulmonary embolism and high-lung opacity scores
    Mohamed Hossameldin khalifa
    Ahmed Samir
    Ayman Ibrahim Baess
    Sara Samy Hendawi
    Egyptian Journal of Radiology and Nuclear Medicine, 52